AI-generated analysis. Always verify with the original filing.
On March 4, 2026, the Compensation Committee of FibroBiologics, Inc. approved a new annual base salary of $400,000 for Chief Financial Officer Jason D. Davis, effective January 1, 2026. His target annual non-equity incentive compensation remains at 40% of base salary.
Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 4, 2
Jason D. Davis
Effective: 2026-01-01